Risk factors of vertebral fractures in women with systemic lupus erythematosus

Clinical Rheumatology

Volumn 28, Issue 5, 2009, Pages 579-585

  Mendoza Pinto, Claudia ^a   García Carrasco, Mario ^a,b   Sandoval Cruz, Hilda ^a   Muñoz Guarneros, Margarita ^b   Escárcega, Ricardo O ^c   Jiménez Hernández, Mario ^a,d   Munguía Realpozo, Pamela ^a   Sandoval Cruz, Manuel ^a   Delezé Hinojosa, Margarita ^e   López Colombo, Aurelio ^a   Cervera, Ricard ^d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

^d HOSPITAL CLÍNIC   (Spain)

^e Hospital Angeles   (Mexico)

Author keywords

Risk factors; Systemic lupus erythematosus; Vertebral fractures

Indexed keywords

ANTIMALARIAL AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; METHOTREXATE; PREDNISONE; VITAMIN D;

ADULT; AGE; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; VERTEBRA FRACTURE;

ADULT; AGE FACTORS; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; HIP; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; OSTEOPOROSIS; POSTMENOPAUSE; REGRESSION ANALYSIS; RISK FACTORS; SPINAL FRACTURES;

EID: 64449087285     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1105-3     Document Type: Article

References (24)

1. Croker JA, Kimberly RP (2005) SLE: Challenges and candidates in human disease. Trends Immunol 26:580-586
2. Galdman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363-369
3. Bultink I, Lems W, Kostense P, Dijkmans BAC, Voskuyl AE (2005) Prevalence of risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 54:2044-2050
4. Borba VZC, Matos PG, da Silva Vianna PR, Fernandes A, Sato EI, Lazaretti-Castro M (2005) High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 14:529-533
5. Wasnich RD (1996) Vertebral fractures epidemiology. Bone 18(3 suppl):179S-183S
6. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJIII (1992) Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota. J Bone Miner Res 7:221-227
7. Melton LJIII, Atkinson EJ, Cooper C, O'Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporos Int 10(3):214-221
8. Black DM, Arden NK, Palermo L, Pearson J, Cummings SR (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14(5):821-828
9. Oleksik A, Lips P, Dawson A, Minsshall ME, Shen W, Cooper C (2000) Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res 15:1384-1392
10. Nevitt MC, Cumming SR, Stone KL et al (2005) Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: The study of osteoporotic fractures. J Bone Miner Res 20(1):131-140
11. Hasserius R, Karlsson B, Jonsson B et al (2005) Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly - a 12- and 22-year follow-up of 257 patients. Calcif Tissue Int 76:235-242
12. Hasserius R, Karlsson MK, Nilsson BE, Redlund-Johnell I, Johnell O (2003) Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: A 10-year population-based study of 598 individuals from Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int 14:61-68
13. Genant HK, Wu CH, Van Kuijk C, Nevitt MC (1993) Vertebral fractures assessment using a semiquantitative technique. J Bone Miner Res 8:1137-1148
14. Stone KL, Seeley DG, Lui LY, Osteoporotic Fractures Research Group et al (2003) BMD at multiple sites and risk of fractures of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res 18:1947-1954
15. Naganathan V, Jones G, Nash P, Nicholson G, Eisman J, Sambrook PN (2000) Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med 160:2917-2922
16. Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54:801-806
17. Selby PL, Halsey JP, Adams KR et al (2000) Corticosteroids do not alter the threshold for vertebral fracture. J Bone Miner Res 15:952-956
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF (1982) The 1982 revised criteria of the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
19. Guzman J, Cardiel MH, Arce-Salinas A, Sanchez-Guerrero J, Alarcon-Segovia D (1992) Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 19:1551-1558
20. Kanis JA, Gluer CC (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisor, International Osteoporosis Foundation. Osteoporos Int 11:192-202
21. Clark P, Cons-Molina F, Deleze M, Ragi S, Haddock L, Zanchetta JR, Jaller JJ, Palermo L, Talavara JO, Messina DO, Morales-Torres J, Salmerpn J, Navarrete A, Suarez E, Pérez CM, Cummings SR (2009) The prevalence of radiographic vertebral fractures in Latin American countries: The Latin American Vertebral Osteoporosis Study (LAVOS. Osteoporos Int 20:275-282
22. Orstavik RE, Haugeberg G, Uhlig T, Mowinckel P, Kvien TK, Falch JA, Halse JI (2004) Quantitative ultrasound and bone mineral density: discriminatory ability in patients with rheumatoid arthritis and controls with and without vertebral deformities. Ann Rheum Dis 63(8):945-951
23. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticosteroids: Potential mechanism of their deleterious effects on bone. J Clin Invest 102:274-282
24. Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S, Giorgino R, Moro L, Giustina A (2006) High prevalence of asymptomatic vertebral fractures in postmenopausal women receiving chronic glucocorticoid therapy: A cross-sectional outpatient study. Bone 39(2):253-259